305 related articles for article (PubMed ID: 11568972)
1. CpG methylation of promoter region inactivates E-cadherin gene in renal cell carcinoma.
Nojima D; Nakajima K; Li LC; Franks J; Ribeiro-Filho L; Ishii N; Dahiya R
Mol Carcinog; 2001 Sep; 32(1):19-27. PubMed ID: 11568972
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin expression is commonly downregulated by CpG island hypermethylation in esophageal carcinoma cells.
Si HX; Tsao SW; Lam KY; Srivastava G; Liu Y; Wong YC; Shen ZY; Cheung AL
Cancer Lett; 2001 Nov; 173(1):71-8. PubMed ID: 11578811
[TBL] [Abstract][Full Text] [Related]
3. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
[TBL] [Abstract][Full Text] [Related]
4. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
Ribeiro-Filho LA; Franks J; Sasaki M; Shiina H; Li LC; Nojima D; Arap S; Carroll P; Enokida H; Nakagawa M; Yonezawa S; Dahiya R
Mol Carcinog; 2002 Aug; 34(4):187-98. PubMed ID: 12203370
[TBL] [Abstract][Full Text] [Related]
5. The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas.
Nakayama S; Sasaki A; Mese H; Alcalde RE; Tsuji T; Matsumura T
Int J Cancer; 2001 Sep; 93(5):667-73. PubMed ID: 11477576
[TBL] [Abstract][Full Text] [Related]
6. Correlation between T-cadherin gene expression and aberrant methylation of T-cadherin promoter in human colon carcinoma cells.
Ren JZ; Huo JR
Med Oncol; 2012 Jun; 29(2):915-8. PubMed ID: 21298366
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.
Kawamoto K; Hirata H; Kikuno N; Tanaka Y; Nakagawa M; Dahiya R
Int J Cancer; 2008 Aug; 123(3):535-42. PubMed ID: 18404682
[TBL] [Abstract][Full Text] [Related]
8. CpG hypermethylation of the promoter region inactivates the estrogen receptor-beta gene in patients with prostate carcinoma.
Nojima D; Li LC; Dharia A; Perinchery G; Ribeiro-Filho L; Yen TS; Dahiya R
Cancer; 2001 Oct; 92(8):2076-83. PubMed ID: 11596023
[TBL] [Abstract][Full Text] [Related]
9. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
Kao RH; Huang LC; Hsu YH
Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
[TBL] [Abstract][Full Text] [Related]
10. [E-cadherin promoter methylation and demethylation in epithelial ovarian carcinoma cells].
Qu PP; Shi Z; Li N
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):538-41. PubMed ID: 19957556
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
Bae SI; Lee HS; Kim SH; Kim WH
Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
[TBL] [Abstract][Full Text] [Related]
12. Promoter methylation regulates cadherin switching in squamous cell carcinoma.
Chen Q; Lipkina G; Song Q; Kramer RH
Biochem Biophys Res Commun; 2004 Mar; 315(4):850-6. PubMed ID: 14985090
[TBL] [Abstract][Full Text] [Related]
13. CpG hypermethylation of the UCHL1 gene promoter is associated with pathogenesis and poor prognosis in renal cell carcinoma.
Kagara I; Enokida H; Kawakami K; Matsuda R; Toki K; Nishimura H; Chiyomaru T; Tatarano S; Itesako T; Kawamoto K; Nishiyama K; Seki N; Nakagawa M
J Urol; 2008 Jul; 180(1):343-51. PubMed ID: 18499164
[TBL] [Abstract][Full Text] [Related]
14. Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.
Mostafavi-Pour Z; Kianpour S; Dehghani M; Mokarram P; Torabinejad S; Monabati A
Pathol Oncol Res; 2015 Sep; 21(4):921-7. PubMed ID: 25743258
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.
Patel AC; Anna CH; Foley JF; Stockton PS; Tyson FL; Barrett JC; Devereux TR
Carcinogenesis; 2000 Sep; 21(9):1691-700. PubMed ID: 10964101
[TBL] [Abstract][Full Text] [Related]
16. DNA mismatch repair genes in renal cell carcinoma.
Deguchi M; Shiina H; Igawa M; Kaneuchi M; Nakajima K; Dahiya R
J Urol; 2003 Jun; 169(6):2365-71. PubMed ID: 12771799
[TBL] [Abstract][Full Text] [Related]
17. Silencing of the thrombomodulin gene in human malignant melanoma.
Furuta J; Kaneda A; Umebayashi Y; Otsuka F; Sugimura T; Ushijima T
Melanoma Res; 2005 Feb; 15(1):15-20. PubMed ID: 15714116
[TBL] [Abstract][Full Text] [Related]
18. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
[TBL] [Abstract][Full Text] [Related]
19. Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma.
Tao J; Liu Q; Wu X; Xu X; Zhang Y; Wang Q; Luo C
Int J Med Sci; 2013; 10(13):1860-7. PubMed ID: 24324362
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
